|
2025 Journal Article MGBase: A Global, Observational Registry for Collaborative Research in Myasthenia GravisBuzzard, Katherine A., Van der Walt, Anneke, Butzkueven, Helmut, Zhang, Wen Wen, Barnett-Tapia, Carolina, Cutter, Gary, Heckmann, Jeannine M., Farr, Pamela, Tran, Carolyn, Sartori, Charlotte, Stupar, Dusko, More, Rein, Sim, Linda, Le, Alison, Tang, Qingxiao, Reddel, Stephen W., Blum, Stefan, Lovas, Gabvor, McCombe, Pamela, Chroni, Elisabeth, Cruse, Belinda, Alroughani, Raed, Tzartos, John, Gomex-Figueroa, Enrique, Boz, Cavit, Karelis, Guntis, Kermode, Allan and Crump, Nicholas (2025). MGBase: A Global, Observational Registry for Collaborative Research in Myasthenia Gravis. Muscle and Nerve, 72 (3) mus.28450, 424-432. doi: 10.1002/mus.28450 |
|
2025 Journal Article Corticosteroid treatment of multiple sclerosis relapses is associated with lower disability worsening over 5 yearsRoberts, Jodie I, Sharmin, Sifat, Horakova, Dana, Kubala Havrdova, Eva, Ozakbas, Serkan, Lugaresi, Alessandra, Tomassini, Valentina, Alroughani, Raed, Buzzard, Katherine, Skibina, Olga, Boz, Cavit, Turkoglu, Recai, Maimone, Davide, Yamout, Bassem, Khoury, Samia Joseph, Spitaleri, Daniele, Lechner-Scott, Jeannette, Girard, Marc, Duquette, Pierre, Al-Asmi, Abdullah, Ampapa, Radek, Foschi, Matteo, Surcinelli, Andrea, Patti, Francesco, Van Pesch, Vincent, Ramo-Tello, Cristina, Sánchez-Menoyo, José Luis, Altintas, Ayse, Grammond, Pierre ... Smirnova, Sonya (2025). Corticosteroid treatment of multiple sclerosis relapses is associated with lower disability worsening over 5 years. Journal of Neurology, Neurosurgery and Psychiatry jnnp-2025-336343, jnnp-2025. doi: 10.1136/jnnp-2025-336343 |
|
2025 Journal Article Correction to: Estimation of Transition Probabilities from a Large Cohort (> 6000) of Australians Living with Multiple Sclerosis (MS) for Changing Disability Severity Classifications, MS Phenotype, and Disease-Modifying Therapy Classifications (PharmacoEconomics, (2024), 10.1007/s40273-024-01417-4)Campbell, Julie A., Henson, Glen J., Ngwa, Valery Fuh, Ahmad, Hasnat, Taylor, Bruce V., van der Mei, Ingrid, Ramanathan, Sudarshini, Hardy, Todd A., Shaw, Cameron, Garber, Justin, Macdonell, Richard, McCombe, Pamela, John, Nevin, Hodgkinson, Suzanne, van der Walt, Anneke, Lechner-Scott, Jeannette, Roos, Izanne, Kalincik, Tomas, Carroll, William M., Fabis-Pedrini, Marzena, Kermode, Allan G., Butzkueven, Helmut and Palmer, Andrew J. (2025). Correction to: Estimation of Transition Probabilities from a Large Cohort (> 6000) of Australians Living with Multiple Sclerosis (MS) for Changing Disability Severity Classifications, MS Phenotype, and Disease-Modifying Therapy Classifications (PharmacoEconomics, (2024), 10.1007/s40273-024-01417-4). PharmacoEconomics, 43 (2), 241-241. doi: 10.1007/s40273-024-01461-0 |
|
2025 Journal Article Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple SclerosisMüller, Jannis, Sharmin, Sifat, Lorscheider, Johannes, Ozakbas, Serkan, Karabudak, Rana, Horakova, Dana, Weinstock-Guttman, Bianca, Shaygannejad, Vahid, Etemadifar, Masoud, Alroughani, Raed, Patti, Francesco, Eichau, Sara, Prat, Alexandre, Lugaresi, Alessandra, Tomassini, Valentina, Kermode, Allan G., Amato, Maria Pia, Turkoglu, Recai, Altintas, Ayse, Buzzard, Katherine, Soysal, Aysun, Van Der Walt, Anneke, Butzkueven, Helmut, Blanco, Yolanda, Gerlach, Oliver, Khoury, Samia J., Barnett, Michael, John, Nevin, Lechner-Scott, Jeannette ... Granziera, Cristina (2025). Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis. JAMA Neurology, 82 (6), 614-625. doi: 10.1001/jamaneurol.2025.0495 |
|
2025 Journal Article Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women’s Health Registry (2020–2024)Jokubaitis, Vilija G, Alroughani, Raed, Altintas, Ayse, Eichau, Sara, Hughes, Stella, Willekens, Barbara, Horakova, Dana, Havrdova, Eva Kubala, Ozakbas, Serkan, Boz, Cavit, Habek, Mario, Kalincik, Tomas, Roos, Izanne, Etemadifar, Masoud, Peterka, Marek, Lechner-Scott, Jeannette, Meca-Lallana, Jose E, Rous, Zuzana, Houskova, Jana, Prat, Alexandre, Girard, Marc, Ampapa, Radek, Buzzard, Katherine, Skibina, Olga, John, Nevin A, Kermode, Allan G, Fabis-Pedrini, Marzena J, Foschi, Matteo, Surcinelli, Andrea ... Kopchak, Oksana (2025). Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women’s Health Registry (2020–2024). Multiple Sclerosis Journal, 31 (9) 13524585251349125, 1088-1101. doi: 10.1177/13524585251349125 |
|
2024 Journal Article Prevalence of progression independent of relapse activity and relapse-associated worsening in patients with AQP4-IgG–positive NMOSDSiriratnam, Pakeeran, Huda, Saif, Van Der Walt, Anneke, Sanfilippo, Paul G., Sharmin, Sifat, Foong, Yi Chao, Yeh, Wei Z., Zhu, Chao, Khoury, Samia J., Csepany, Tunde, Willekens, Barbara, Etemadifar, Masoud, Ozakbas, Serkan, Nytrova, Petra, Altintas, Ayse, Al-Asmi, Abdullah, Ramo-Tello, Cristina M., Laureys, Guy, Patti, Francesco, Horakova, Dana, Foschi, Matteo, Boz, Cavit, McCombe, Pamela A., Turkoglu, Recai, Lechner-Scott, Jeannette, Roos, Izanne, Kalincik, Tomas, Jokubaitis, Vilija G., Butzkueven, Helmut ... for MSBase (2024). Prevalence of progression independent of relapse activity and relapse-associated worsening in patients with AQP4-IgG–positive NMOSD. Neurology, 103 (12) e209940, 1-8. doi: 10.1212/wnl.0000000000209940 |
|
2024 Journal Article Disease activity in pregnant and postpartum women with multiple sclerosis receiving ocrelizumab or other disease-modifying therapiesYeh, Wei Z., Van Der Walt, Anneke, Skibina, Olga G., Kalincik, Tomas, Alroughani, Raed, Kermode, Allan G., Fabis-Pedrini, Marzena J., Carroll, William M., Lechner-Scott, Jeannette, Boz, Cavit, Ozakbas, Serkan, Buzzard, Katherine, Habek, Mario, John, Nevin A., Prat, Alexandre, Girard, Marc, Duquette, Pierre, Baghbanian, Seyed Mohammad, Hodgkinson, Suzanne, Van Pesch, Vincent, Laureys, Guy, Willekens, Barbara, Prevost, Julie, Foschi, Matteo, De Gans, Koen, Horakova, Dana, Havrdova, Eva Kubala, Karabudak, Rana, Patti, Francesco ... for the MSBase Study Group (2024). Disease activity in pregnant and postpartum women with multiple sclerosis receiving ocrelizumab or other disease-modifying therapies. Neurology Neuroimmunology and Neuroinflammation, 11 (6) e200328, 1-16. doi: 10.1212/nxi.0000000000200328 |
|
2024 Journal Article Effectiveness of disease-modifying treatment on spinal cord lesion formation in relapse-onset multiple sclerosis: an MSBase registry studyKreiter, Daniel, Kalincik, Tomas, Hupperts, Raymond, Patti, Francesco, Spitaleri, Daniele, Foschi, Matteo, Surcinelli, Andrea, Maimone, Davide, Yamout, Bassem, Khoury, Samia J., Lechner-Scott, Jeannette, Ozakbas, Serkan, Gerlach, Oliver, Turkoglu, R., Soysal, A., Boz, C., Al-Asmi, A., Alkhaboori, J., Amato, M. P., Onofrj, M., Lugaresi, A., Besora, S., Sanchez-Menoyo, J. L., Lapointe, E., Grand’Maison, F., Grammond, P., Butzkueven, H., Van der Walt, A., Taylor, B. V. ... Barnett, M. H. (2024). Effectiveness of disease-modifying treatment on spinal cord lesion formation in relapse-onset multiple sclerosis: an MSBase registry study. CNS Drugs, 38 (11), 921-930. doi: 10.1007/s40263-024-01115-x |
|
2024 Journal Article Assessing the effect of Riluzole on motor unit discharge propertiesShandiz, Ehsan, Fernandes, Gabriel Lima, Henkin, Joao Saldanha, McCombe, Pamela Ann, Trajano, Gabriel Siqueira and Henderson, Robert David (2024). Assessing the effect of Riluzole on motor unit discharge properties. Brain Sciences, 14 (11) 1053, 1053. doi: 10.3390/brainsci14111053 |
|
2024 Journal Article Diagnosing late-onset Tay-Sachs through next generation sequencing and functional enzyme testing: from genes to enzymesTupil, Ajay R., Rivlin, Warwick, Mccombe, Pamela A., Henderson, Robert D., Rodgers, Jonathan and Vadlamudi, Lata (2024). Diagnosing late-onset Tay-Sachs through next generation sequencing and functional enzyme testing: from genes to enzymes. Neurology Genetics, 10 (6) e200205, e200205. doi: 10.1212/nxg.0000000000200205 |
|
2024 Journal Article Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre studySiriratnam, Pakeeran, Sanfilippo, Paul, van der Walt, Anneke, Sharmin, Sifat, Foong, Yi Chao, Yeh, Wei Zhen, Zhu, Chao, Khoury, Samia Joseph, Csepany, Tunde, Willekens, Barbara, Etemadifar, Masoud, Ozakbas,, Serkan, Nytrova, Petra, Altintas, Ayse, Al-Asmi, Abdullah, Yamout, Bassem, Laureys, Guy, Patti, Francesco, Simo, Magdolna, Surcinelli, Andrea, Foschi, Matteo, McCombe, Pamela A, Alroughani, Raed, Sánchez-Menoyo, José Luis, Turkoglu, Recai, Soysal, Aysun, Lechner Scott, Jeanette, Kalincik, Tomas, Butzkueven, Helmut ... Monif, Mastura (2024). Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study. Journal of Neurology, Neurosurgery and Psychiatry, 96 (4) jnnp-2024-334090, 1-9. doi: 10.1136/jnnp-2024-334090 |
|
2024 Journal Article Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosisRoos, Izanne, Sharmin, Sifat, Malpas, Charles, Ozakbas, Serkan, Lechner-Scott, Jeannette, Hodgkinson, Suzanne, Alroughani, Raed, Eichau Madueño, Sara, Boz, Cavit, van der Walt, Anneke, Butzkueven, Helmut, Buzzard, Katherine, Skibina, Olga, Foschi, Matteo, Grand’Maison, Francois, John, Nevin, Grammond, Pierre, Terzi, Murat, Prévost, Julie, Barnett, Michael, Laureys, Guy, Van Hijfte, Liesbeth, Luis Sanchez-Menoyo, Jose, Blanco, Yolanda, Oh, Jiwon, McCombe, Pamela, Ramo Tello, Cristina, Soysal, Aysun, Prat, Alexandre ... Kalincik, Tomas (2024). Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal, 30 (9), 1163-1175. doi: 10.1177/13524585241267211 |
|
2024 Journal Article Generation of human induced pluripotent stem cell lines from sporadic, sporadic frontotemporal dementia, familial SOD1, and familial C9orf72 amyotrophic lateral sclerosis (ALS) patientsJiang, Leanne, Tracey, Timothy J., Gill, Melinder K., Howe, Stephanie L., Power, Dominique T., Bharti, Vanda, McCombe, Pamela A., Henderson, Robert D., Steyn, Frederik J. and Ngo, Shyuan T. (2024). Generation of human induced pluripotent stem cell lines from sporadic, sporadic frontotemporal dementia, familial SOD1, and familial C9orf72 amyotrophic lateral sclerosis (ALS) patients. Stem Cell Research, 78 103447, 1-6. doi: 10.1016/j.scr.2024.103447 |
|
2024 Journal Article The clinical relevance of MOG antibody testing in cerebrospinal fluidReynolds, Molly, Tan, Irene, Nguyen, Kristy, Merheb, Vera, Lee, Fiona X. Z., Trewin, Benjamin P, Lerch, Magdalena, Shah, Snehal, Wolfe, Nigel, Buzzard, Katherine, Lechner-Scott, Jeannette, Fabis-Pedrini, Marzena, Fok, Anthony, John, Nevin, Kneebone, Chris, Yiannikas, Con, Brown, David A., Kermode, Allan G., Reddel, Stephen, Dale, Russell C., Brilot, Fabienne, Ramanathan, Sudarshini, Adam, Robert, Andersen, Jane, Andrews, Ian, Antony, Jayne, Aouad, Patrick, Badve, Monica, Barnett, Michael H. ... on behalf of the Australasian MOGAD Study Group (2024). The clinical relevance of MOG antibody testing in cerebrospinal fluid. Annals of Clinical and Translational Neurology, 11 (9), 1-6. doi: 10.1002/acn3.52163 |
|
2024 Journal Article General neurology: Current challenges and future implicationsBassetti, Claudio Lino Alberto, Accorroni, Alice, Arnesen, Astri, Basri, Hamidon Bin, Berger, Thomas, Berlit, Peter, Boon, Paul, Charway-Felli, Augustina, Kruja, Jera, Lewis, Steven, Markowski, Michael, Medina, Marco Tulio, McComb, Pamela, Moro, Elena, Ozturk, Serefnur, Smith, Paul and Vuletic, Vladimira (2024). General neurology: Current challenges and future implications. European Journal of Neurology, 31 (6) e16237, 1-11. doi: 10.1111/ene.16237 |
|
2024 Journal Article A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemicLal, Anoushka P., Foong, Yi Chao, Sanfilippo, Paul G., Spelman, Tim, Rath, Louise, Levitz, David, Fabis-Pedrini, Marzena, Foschi, Matteo, Habek, Mario, Kalincik, Tomas, Roos, Izanne, Lechner-Scott, Jeannette, John, Nevin, Soysal, Aysun, D’Amico, Emanuele, Gouider, Riadh, Mrabet, Saloua, Gross-Paju, Katrin, Cárdenas-Robledo, Simón, Moghadasi, Abdorreza Naser, Sa, Maria Jose, Gray, Orla, Oh, Jiwon, Reddel, Stephen, Ramanathan, Sudarshini, Al-Harbi, Talal, Altintas, Ayse, Hardy, Todd A., Ozakbas, Serkan ... Van der Walt, Anneke (2024). A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic. Journal of Neurology, 271 (9), 5813-5824. doi: 10.1007/s00415-024-12518-7 |
|
2024 Journal Article Verbal and nonverbal fluency in amyotrophic lateral sclerosisBarker, Megan S., Ceslis, Amelia, Argall, Rosemary, McCombe, Pamela, Henderson, Robert D. and Robinson, Gail A. (2024). Verbal and nonverbal fluency in amyotrophic lateral sclerosis. Journal of Neuropsychology, 18 (2), 265-285. doi: 10.1111/jnp.12354 |
|
2024 Journal Article Neutrophil-to-lymphocyte ratio at diagnosis as a biomarker for survival of amyotrophic lateral sclerosisNona, Robert J., Henderson, Robert D. and McCombe, Pamela A. (2024). Neutrophil-to-lymphocyte ratio at diagnosis as a biomarker for survival of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 25 (5-6), 452-464. doi: 10.1080/21678421.2024.2351187 |
|
2024 Journal Article Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort studyDekeyser, Cathérine, Hautekeete, Matthias, Cambron, Melissa, Van Pesch, Vincent, Patti, Francesco, Kuhle, Jens, Khoury, Samia, Lechner Scott, Jeanette, Gerlach, Oliver, Lugaresi, Alessandra, Maimone, Davide, Surcinelli, Andrea, Grammond, Pierre, Kalincik, Tomas, Habek, Mario, Willekens, Barbara, Macdonell, Richard, Lalive, Patrice, Csepany, Tunde, Butzkueven, Helmut, Boz, Cavit, Tomassini, Valentina, Foschi, Matteo, Sánchez-Menoyo, José Luis, Altintas, Ayse, Mrabet, Saloua, Iuliano, Gerardo, Sa, Maria Jose, Alroughani, Raed ... Laureys, Guy (2024). Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study. Journal of Neurology, Neurosurgery and Psychiatry, 95 (11) 23333307, 1021-1031. doi: 10.1136/jnnp-2023-333307 |
|
2024 Journal Article Long-term efficacy and safety of Rituximab in the treatment of neuromyelitis optica spectrum disorderHayes, Michael Thomas Gerard, Adam, Robert J., McCombe, Pamela Ann, Walsh, Michael and Blum, Stefan (2024). Long-term efficacy and safety of Rituximab in the treatment of neuromyelitis optica spectrum disorder. Multiple Sclerosis Journal, 10 (2) 20552173241257876, 20552173241257876. doi: 10.1177/20552173241257876 |
